Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XQN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,294
Award facts
- Contract value 100% obligated
- $24,293.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,293.60 on August 11, 2025, for the supply of Jakafi 5 mg tablets (60-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, was issued without a set-aside designation by the Defense Logistics Agency's Medical Supply Chain under the SPE2DB Indefinite Delivery Contract program. The product will be delivered to Park Ridge, Illinois, and represents a specialized pharmaceutical supply supporting the Department of Defense's healthcare requirements.
This delivery order falls under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract with the Defense Logistics Agency, valid through November 2026. The contract vehicle enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables serving military health facilities. Jakafi, a prescription medication, exemplifies the specialized pharmaceutical portfolio the company routinely supplies to federal healthcare systems. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, combined with its woman-owned small business status, positions it competitively for recurring delivery orders across the Defense Department's medical supply needs.
Quick answers
Who was awarded contract SPE2DX25F6XQN?
SPE2DX25F6XQN was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 11, 2025.
How much is contract SPE2DX25F6XQN worth?
The government has obligated $24,294 on SPE2DX25F6XQN.
Is contract SPE2DX25F6XQN an order under another contract?
Yes. SPE2DX25F6XQN is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XQN competed?
The extent of competition for SPE2DX25F6XQN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award